Concepedia

Haowen Xu

HX

5

Publications

163

Citations

5

H-Index

2022

Active since

Affiliations

Wenzhou Medical University(Current)

Hangzhou Medical College

First Affiliated Hospital of Wenzhou Medical University

Haowen Xu is an author at Wenzhou Medical University specializing in cell signaling, inflammation, and medicine.

Top concepts

Publications per year

2022–2023

5

Publications

5

Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases

Haowen Xu, Jiahao Chen, Pan Chen et al. · Acta Pharmaceutica Sinica B · 2022 · 75 citations · Full text

Discovery of alantolactone as a naturally occurring NLRP3 inhibitor to alleviate NLRP3‐driven inflammatory diseases in mice

Weifeng Li, Haowen Xu, Jingjing Shao et al. · British Journal of Pharmacology · 2023 · 29 citations · Full text

Tabersonine, a natural NLRP3 inhibitor, suppresses inflammasome activation in macrophages and attenuate NLRP3-driven diseases in mice

Haowen Xu, Weifeng Li, Shanshan Hong et al. · Acta Pharmacologica Sinica · 2023 · 28 citations · Full text

, , +12

Doublecortin-like kinase 1 activates NF-κB to induce inflammatory responses by binding directly to IKKβ

Wu Luo, Yiyi Jin, Yuchen Jiang et al. · Cell Death and Differentiation · 2023 · 17 citations · Full text

, , +12

Ergolide covalently binds NLRP3 and inhibits NLRP3 inflammasome-mediated pyroptosis

Miao Ren, Jiahao Chen, Haowen Xu et al. · International Immunopharmacology · 2023 · 14 citations

, , +8

Rows per page

1–5 of 5